Print

March 7, 2016

SUMMARY

The American Pain Society last month released a set of Clinical Practice Guidelines on the Management of Postoperative Pain. The key recommendation in the Guidelines is for greater use of multimodal pain management strategies.

 

The American Pain Society (APS) last month released its first-ever Clinical Practice Guidelines on the Management of Postoperative Pain.  The American Society of Anesthesiologists, which published its own Practice Guidelines for Acute Pain Management in the Perioperative Setting in Anesthesiology in 2012, provided input, and the American Society for Regional Anesthesia endorsed the APS Guidelines.

"The intent of the guideline is to provide evidence-based recommendations for better management of postoperative pain, and the target audience is all clinicians who manage pain resulting from surgery," said principal author Roger Chou, MD of the Departments of Medicine and Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Pacific Northwest Evidence Based Practice Center.  (APS News Release, February 17, 2016.)  Studies have shown again and again that the majority of surgical patients receive inadequate pain control, which can increase the risks of persistent postoperative pain and of post-surgical complications, function and functional recovery, and quality of life.

The key recommendation in the Guidelines is for greater use of multimodal pain management strategies.  Multimodal techniques, according to Dr. Chou, help achieve better pain relief while lowering doses of opioids and potentially avoiding certain adverse effects, by affecting pain through different pathways and mechanisms of action.  Dr. Chou further explained that using a multimodal approach “means using different medications, for example opioids and nonopioid therapies such as non-steroidal anti-inflammatories (NSAIDs), gabapentin/pregabalin, ketamine, lidocaine, administered in different ways, for example, systemically or via neuraxial/peripheral regional anesthetic techniques, as well as medications and nonpharmacological therapies."

The Guidelines contain 32 recommendations developed by a panel of 23 experts in anesthesia, pain medicine, surgery, obstetrics and gynecology, pediatrics, hospital medicine, nursing, primary care, physical therapy and psychology who reviewed nearly 1,000 primary studies and systematic reviews.  Although the process required only a two-thirds majority for a recommendation to be approved, unanimity or a near-unanimous consensus was achieved in each case. 

Each recommendation received a separate grade for the strength of the recommendation (strong or weak) and for the quality of evidence (high, moderate, or low).  Four recommendations received the highest ratings in both domains (strong recommendation, high-quality evidence):

The following recommendations are among those also rated “strong” albeit based on “moderate” quality evidence:

The panel issued a third group of strong recommendations despite “low” quality evidence, including:

Some of the recommendations were “weak” even if supported by moderate evidence.  Among these recommendations were:

Finally, the panel found itself unable either to recommend or to discourage acupuncture, massage, or cold therapy as adjuncts to other postoperative pain treatments because of insufficient evidence.  The panel concluded by noting that there remain numerous research gaps.  Of 32 recommendations, the panel rated only four as supported by high-quality evidence, and 11 recommendations were based on low-quality evidence

What impact will the new Guidelines have?  They are intended, as noted above, to help physicians and other clinicians achieve optimal pain management following surgery.  Given the intense health policy emphasis on the management of pain in general, hospitals may actively promote adherence to the Guidelines, which affirm the 2012 ASA Practice Guidelines’ recommendation that:

Whenever possible, anesthesiologists should use multimodal pain management therapy.  Central regional blockade with local anesthetics should be considered. Unless contraindicated, patients should receive an around-the-clock regimen of COXIBs, NSAIDs, or acetaminophen.  Dosing regimens should be administered to optimize efficacy while minimizing the risk of adverse events.  The choice of medication, dose, route, and duration of therapy should be individualized.

Any changes in clinical practice that the APS Guidelines may bring about are likely to occur over time.  Any changes in payment policies, such as requiring documented consideration of oral pain medications and relaxation therapy before administration of neural blockade, will come about slowly if at all—but anesthesiologists should certainly recognize that changes are possible and begin to update their own practices as appropriate.

With best wishes,

Tony Mira
President and CEO